Association between clopidogrel use and improved survival in critically ill patients with acute kidney injury: insights from MIMIC-IV database
Abstract Background Acute kidney injury (AKI) remains a frequent complication in intensive care unit (ICU) settings. Clopidogrel, a P2Y12 receptor inhibitor, has been reported to possess anti-inflammatory, antioxidant, immunomodulatory, and anti-apoptotic effects. However, evidence regarding its sur...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-12-01
|
| Edice: | BMC Nephrology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12882-025-04673-4 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
